Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma
NCT00978913
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Malignant Melanoma
Interventions
BIOLOGICAL:
DC vaccine
Sponsor
Inge Marie Svane